Fortress Biotech, Inc. (FBIO)

2.735 -0.04 (-1.26%) USD  |  NASDAQ  |  Aug 31, 16:00
2.74 0.00 (0.00%) After-Hours: 20:00
More

Fortress Biotech Cash and Short Term Investments (Quarterly) : 196.58M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for FBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 196.58M
March 31, 2026 255.84M
December 31, 2025 79.38M
September 30, 2025 86.22M
June 30, 2025 74.39M
March 31, 2025 91.34M
December 31, 2024 57.26M
September 30, 2024 58.85M
June 30, 2024 76.20M
March 31, 2024 85.84M
December 31, 2023 80.93M
September 30, 2023 74.74M
June 30, 2023 86.77M
March 31, 2023 152.48M
December 31, 2022 178.27M
September 30, 2022 208.35M
June 30, 2022 248.77M
March 31, 2022 287.51M
December 31, 2021 305.74M
September 30, 2021 252.72M
June 30, 2021 274.99M
March 31, 2021 289.90M
December 31, 2020 233.35M
September 30, 2020 218.39M
June 30, 2020 183.28M
Date Value
March 31, 2020 135.94M
December 31, 2019 136.86M
September 30, 2019 154.87M
June 30, 2019 154.41M
March 31, 2019 121.49M
December 31, 2018
September 30, 2018 125.42M
June 30, 2018 138.24M
March 31, 2018 166.34M
December 31, 2017 152.94M
September 30, 2017 157.26M
June 30, 2017 168.83M
March 31, 2017 136.27M
December 31, 2016 91.68M
September 30, 2016 85.74M
June 30, 2016 71.34M
March 31, 2016 81.42M
December 31, 2015 98.18M
September 30, 2015 65.51M
June 30, 2015 61.04M
March 31, 2015 68.93M
December 31, 2014 69.76M
September 30, 2014 71.59M
June 30, 2014 76.04M
March 31, 2014 79.98M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. 36.67M
Ironwood Pharmaceuticals, Inc. 79.13M
Kura Oncology, Inc. 519.02M
Spero Therapeutics, Inc. 50.77M
Cue Biopharma, Inc. 17.39M